Cost containment interventions introduced on the community drugs schemes in Ireland-evaluation of expenditure trends using a national prescription claims database.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Affiliation
National Centre for Pharmacoeconomics, St James's Hospital, Dublin, Ireland. cusher@stjames.ieIssue Date
2012-03MeSH
Cost ControlCosts and Cost Analysis
Databases, Factual
Drug Costs
Health Expenditures
Insurance Claim Review
Insurance, Health, Reimbursement
Ireland
Prescription Drugs
State Medicine
Metadata
Show full item recordCitation
Cost containment interventions introduced on the community drugs schemes in Ireland-evaluation of expenditure trends using a national prescription claims database. 2012, 34 (3):632-9 Clin TherPublisher
Clinical therapeuticsJournal
Clinical therapeuticsDOI
10.1016/j.clinthera.2012.01.025PubMed ID
22381716Additional Links
http://www.ncbi.nlm.nih.gov/pubmed/22381716Abstract
The majority of pharmaceutical expenditure in Ireland occurs in the community for services provided by general practitioners and pharmacists. In the current national and international economic climate, it is anticipated that demand on these services will continue to grow.Language
enISSN
1879-114Xae974a485f413a2113503eed53cd6c53
10.1016/j.clinthera.2012.01.025
Scopus Count
Collections
Related articles
- Public drug expenditure in the Republic of Ireland.
- Authors: Barry M, Usher C, Tilson L
- Issue date: 2010 Jun
- The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland.
- Authors: Tilson L, Bennett K, Barry M
- Issue date: 2005 Sep
- The implications of regional and national demographic projections for future GMS costs in Ireland through to 2026.
- Authors: Conway A, Kenneally M, Woods N, Thummel A, Ryan M
- Issue date: 2014 Oct 21
- Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.
- Authors: Andersson K, Bergström G, Petzold MG, Carlsten A
- Issue date: 2007 May
- The effects of new pricing and copayment schemes for pharmaceuticals in South Korea.
- Authors: Lee IH, Bloor K, Hewitt C, Maynard A
- Issue date: 2012 Jan